Wang, C., Lin, Y., Zhou, Y., Mao, F., Zhu, H., Guan, J., . . . Sun, Q. (2020). Pyrotinib with trastuzumab and aromatase inhibitors as first-line treatment for HER2 positive and hormone receptor positive metastatic or locally advanced breast cancer: Study protocol of a randomized controlled trial. BMC Cancer.
シカゴスタイル引用形Wang, Changjun, et al. "Pyrotinib With Trastuzumab and Aromatase Inhibitors As First-line Treatment for HER2 Positive and Hormone Receptor Positive Metastatic or Locally Advanced Breast Cancer: Study Protocol of a Randomized Controlled Trial." BMC Cancer 2020.
MLA引用形式Wang, Changjun, et al. "Pyrotinib With Trastuzumab and Aromatase Inhibitors As First-line Treatment for HER2 Positive and Hormone Receptor Positive Metastatic or Locally Advanced Breast Cancer: Study Protocol of a Randomized Controlled Trial." BMC Cancer 2020.